Heterogeneous germline mutations in the p53 gene are linked to Li-Fraumeni syndrome (LFS), and these patients are predisposed to develop a wide spectrum of cancers at younger ages (41% by age 18 years) than the general population26. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.